July 31, 2019
In The News
Mel Yeates from DDNews reports on some of Atomwise’s recent partnerships with Eli Lilly and Enamine.
Mel Yeates from DDNews reports on some of Atomwise’s recent partnerships with Eli Lilly and Enamine.
Having signed a multi-year, multi-target agreement with Lilly worth potentially $550m, Atomwise CEO Abe Heifets tells Scrip the burden of proof is on AI practitioners to start producing relevant and actionable data.